Parambi, R. et al. 2022. Crosstalk between hemostasis inhibitors and cholesterol biomarkers in multiple sclerosis. Bleeding, Thrombosis and Vascular Biology. 1, 3 (Oct. 2022). DOI:https://doi.org/10.4081/btvb.2022.41.